KREBS BIOCHEMICALS & INDUSTRIES
Back to All Ratios
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Core EBITDA Margin History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Core EBITDA Margin(%) | -34.70 | -17.30 | -30.27 | -56.94 | -32.73 |
What is the latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Core EBITDA Margin |
|---|---|
| Mar2025 | -34.70 |
| Mar2024 | -17.30 |
| Mar2023 | -30.27 |
| Mar2022 | -56.94 |
| Mar2021 | -32.73 |
How is Core EBITDA Margin of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Core EBITDA Margin | % Change | |
|---|---|---|---|
| Mar2025 | -34.7 | Negative | |
| Mar2024 | -17.3 | Negative | |
| Mar2023 | -30.27 | Negative | |
| Mar2022 | -56.94 | Negative | |
| Mar2021 | -32.73 | - | |
Other Financial Ratios of KREBS BIOCHEMICALS & INDUSTRIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹138.4 Cr | -3.5% | 3.1% | -14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | -3.5% |
3.1% |
-14.4% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses